We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Alternative Agents for the Treatment of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Strains With Reduced Susceptibility to Vancomycin

Pierre Tattevin, MD; Cédric Arvieux, MD; Christian Michelet, MD, PhD
Arch Intern Med. 2007;167(11):1206. doi:10.1001/archinte.167.11.1206-a.
Text Size: A A A
Published online


In a recently published article, Hidayat et al1 observed a high prevalence of clinical methicillin-resistant Staphylococcus aureus (MRSA) strains with an elevated vancomycin minimum inhibitory concentration (2 μg/mL) in a prospective cohort, and they studied treatment outcomes with high-dose vancomycin hydrochloride. The authors concluded that (1) these strains require aggressive empirical vancomycin dosing to achieve trough plasma concentrations greater than 15 μg/mL and (2) combination or alternative therapy should be considered for invasive infections caused by these strains.1 Although they provide convincing data supporting the first part of this conclusion, the reader may feel disappointed with the data supporting the second part (ie, the place of combination or alternative therapy). Indeed, of the 95 patients included in this study, only 15 received vancomycin in combination with linezolid, daptomycin, and/or rifampin, and the only information we have about them from this article is that “the end-of-treatment response appeared more favorable when compared with vancomycin alone.”1(p2143) About the subsets of patients in whom vancomycin was switched to another therapy in this study, the authors provided more data: in the “Comment” section, we learn that 12 (80%) of the 15 patients responded to nonvancomycin therapy, but the list of alternative agents received by these 15 patients is limited to daptomycin (n = 6), linezolid (n = 3), and rifampin (n = 6), which would suggest that 6 of them received rifampin as a monotherapy. However, since it is well acknowledged that the use of rifampin as a single agent for the treatment of S aureus infections is limited by a high rate of development of resistance during therapy, as early as within the first 24 to 48 hours of exposure,2 these patients probably received rifampin in combination with other antistaphylococcal agents in this study, even if this is not stipulated in the article.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles